Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a fully integrated, late-stage biotechnology company advancing a sustainable pipeline of genetic therapies for rare disorders with high unmet need, today ...
Google Cloud’s lead engineer for databases discusses the challenges of integrating databases and LLMs, the tools needed to ...
While in the mid-2010s the country’s nominal gross domestic product stood at approximately USD 60-65 billion, it has now ...
Retrieval-augmented generation breaks at scale because organizations treat it like an LLM feature rather than a platform ...
Paris, Jan. 06, 2026 (GLOBE NEWSWIRE) -- 88% reduction in urinary incontinence episodes in patients with neurogenic bladder sustained through ...
Novel capsid technology to enable convenient delivery in the doctor’s office of IKAR-003 for intermediate AMD, designed to prevent progression to sight-threatening disease ...
Rocket Pharmaceuticals is a Buy, with strong catalysts, undervalued programs, and significant upside. Click here to read my ...
Precision BioSciences offers high-risk, high-reward potential, trading below cash with key HBV and DMD data catalysts ...
A research team affiliated with UNIST has made a advancement in controlling spin-based signals within a new magnetic material ...
Recently, micro/nanosatellites have become a significant trend in space with the rapid development of space technology, ...
In 2026, banks face converging pressure from AI, fraud, and data demands. Why hesitation is a competitive risk—and what ...
Data collected under the Death in Custody Reporting Act has some serious problems. Here’s how we fixed some of them.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback